GLIDAPA 3D 10/100/500 SR: Uses, and Side Effects

GLIDAPA 3D 10/100/500 SR

Dapaflozin 10 mg, Sitagliptin 100 mg & Metformin SR 500 mg

GLIDAPA 3D 10/100/500 SR is a combination medication used to manage type 2 diabetes mellitus. It combines three key components—Dapaflozin, Sitagliptin, and Metformin SR—into a single, sustained-release formulation. This combination aims to effectively control blood glucose levels in patients who need a multi-faceted approach to diabetes management.

Components and Dosage

Dapaflozin 10 mg: Dapaflozin is a selective SGLT2 inhibitor that helps lower blood glucose by preventing glucose reabsorption in the kidneys. This results in increased glucose excretion through urine.
Sitagliptin 100 mg: Sitagliptin is a DPP-4 inhibitor that enhances insulin secretion and decreases glucagon levels, thus improving blood sugar control.
Metformin SR 500 mg: Metformin is a biguanide that reduces glucose production in the liver and improves insulin sensitivity. The sustained-release formulation helps minimize gastrointestinal side effects.
Mechanism of Action

Dapaflozin: Inhibits the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, which leads to increased urinary glucose excretion and lower blood glucose levels.
Sitagliptin: Inhibits the enzyme DPP-4, which prolongs the action of incretin hormones that stimulate insulin secretion and reduce blood glucose levels.
Metformin: Decreases hepatic glucose production and enhances insulin sensitivity in peripheral tissues, aiding in better glucose uptake and utilization.
Benefits

Effective Blood Sugar Control: The combination of these three agents provides a comprehensive approach to managing blood glucose levels, addressing different aspects of glucose regulation.
Reduced Risk of Hypoglycemia: The medications in GLIDAPA 3D generally have a lower risk of causing hypoglycemia compared to other glucose-lowering treatments.
Convenience: The sustained-release formulation means fewer doses per day, improving patient adherence to the treatment regimen.
Usage and Administration
GLIDAPA 3D 10/100/500 SR is typically taken once daily with food to reduce the risk of gastrointestinal side effects. Dosage should be individualized based on the patient's current glycemic control, tolerance, and response to therapy.

Side Effects
Common side effects may include gastrointestinal issues such as nausea, diarrhea, or abdominal pain. Additionally, there might be an increased risk of urinary tract infections and potential for dehydration due to the SGLT2 inhibitor component. 
Conclusion
GLIDAPA 3D 10/100/500 SR is a well-rounded option for individuals with type 2 diabetes, combining the benefits of Dapaflozin, Sitagliptin, and Metformin SR in a single pill. Its multifaceted approach helps in better management of blood glucose levels, contributing to improved overall diabetes control.Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. 

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488  

BUY NOW